In Vivo Radioimaging of Bradykinin Receptor B1, a Widely Overexpressed Molecule in Human Cancer

作者: Kuo-Shyan Lin , Jinhe Pan , Guillaume Amouroux , Gulisa Turashvili , Felix Mesak

DOI: 10.1158/0008-5472.CAN-14-1603

关键词: Bradykinin receptorReceptor-mediated endocytosisBiochemistryCancerIn vivoPhosphoramidonBradykinin receptor B1ChemistryCancer researchKallidinIn vitro

摘要: The bradykinin receptor B1R is overexpressed in many human cancers where it might be used as a general target for cancer imaging. In this study, we evaluated the feasibility of using radiolabeled kallidin derivatives to visualize expression preclinical model B1R-positive tumors. Three synthetic were vitro and vivo binding their ability tumors by PET. Enalaprilat phosphoramidon evaluate impact peptidases on tumor visualization. While found that peptides based native sequence ineffective at visualizing tumors, peptidase inhibition with greatly enhanced visualization . Two stabilized incorporating unnatural amino acids ( 68 Ga-SH01078 Ga-P03034) maintained receptor-binding affinities effective, allowing excellent visualization, minimal accumulation normal tissues, rapid renal clearance. Tumor uptake was blocked presence excess competitor, confirming specificity mediated. Our results offer proof concept noninvasive detection PET imaging tool cancers. Cancer Res; 75(2); 387–93. ©2014 AACR.

参考文章(19)
Antti Kuoppala, Ken A. Lindstedt, Juhani Saarinen, Petri T. Kovanen, Jorma O. Kokkonen, Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma. American Journal of Physiology-heart and Circulatory Physiology. ,vol. 278, ,(2000) , 10.1152/AJPHEART.2000.278.4.H1069
Pamela Ehrenfeld, Ivan Conejeros, Maria F. Pavicic, Carola E. Matus, Carlos B. Gonzalez, Andrew F.G. Quest, Kanti D. Bhoola, Maria T. Poblete, Rafael A. Burgos, Carlos D. Figueroa, Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells Cancer Letters. ,vol. 301, pp. 106- 118 ,(2011) , 10.1016/J.CANLET.2010.09.020
Elena Kashuba, James Bailey, David Allsup, Lynn Cawkwell, The kinin-kallikrein system: physiological roles, pathophysiology and its relationship to cancer biomarkers. Biomarkers. ,vol. 18, pp. 279- 296 ,(2013) , 10.3109/1354750X.2013.787544
John M Stewart, Daniel C Chan, Vitalija Simkeviciene, Paul A Bunn, Barbara Helfrich, Eunice J York, Laimute Taraseviciene-Stewart, Daiva Bironaite, Lajos Gera, Bradykinin antagonists as new drugs for prostate cancer. International Immunopharmacology. ,vol. 2, pp. 1781- 1786 ,(2002) , 10.1016/S1567-5769(02)00181-9
Luis Molina, Carola E. Matus, Angel Astroza, Francisca Pavicic, Eugenio Tapia, Cesar Toledo, Juan A. Perez, Francisco Nualart, Carlos B. Gonzalez, Rafael A. Burgos, Carlos D. Figueroa, Pamela Ehrenfeld, Maria T. Poblete, Stimulation of the bradykinin B(1) receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway. Breast Cancer Research and Treatment. ,vol. 118, pp. 499- 510 ,(2009) , 10.1007/S10549-009-0314-4
Wilhelm Stahl, Gerhard Breipohl, Ludwig Kuhlmann, Axel Steinstraesser, Hermann J. Gerhards, Bernward A. Schoelkens, Technetium-99m-labeled HOE 140: a potential bradykinin B2 receptor imaging agent. Journal of Medicinal Chemistry. ,vol. 38, pp. 2799- 2801 ,(1995) , 10.1021/JM00015A001
M. Fani, F. Braun, B. Waser, K. Beetschen, R. Cescato, J. Erchegyi, J. E. Rivier, W. A. Weber, H. R. Maecke, J. C. Reubi, Unexpected Sensitivity of sst2 Antagonists to N-Terminal Radiometal Modifications The Journal of Nuclear Medicine. ,vol. 53, pp. 1481- 1489 ,(2012) , 10.2967/JNUMED.112.102764